Trials / Unknown
UnknownNCT03044067
Effects of Pain Neuroscience Education in Fibromyalgia
The Effects of Pain Neuroscience Education Plus Exercise in the Management of Fibromyalgia: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of Malaga · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Fibromyalgia is one of the main causes of chronic musculoskeletal widespread pain. This condition presents a global prevalence of 2.7%, and it is more prevalent in women (with a female to male ratio of 3:1) over 50 years of age with low education level and low socioeconomic status, living in rural areas. High direct medical costs and significant indirect costs of this condition can't be ignored.
Detailed description
Study design and setting: The design of the present study will be a randomized controlled trial with 2 follow-ups (one week and one month after intervention) that will be performed between May 2017 and June 2017 in one private clinic in Malaga, Spain. The outcomes will be assessed at baseline (t1), one week after intervention (t2), and one moth after intervention (t3). Written informed consent will be acquired for all participants prior to their participation. The study will be implemented and reported in line with the CONSORT statement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pain neuroscience education + Exercise | A session of Pain neuroscience education + Exercise covers the activity, strength and endurance of lower and upper muscles of the extremities. Besides that it will be covered the understanding and acknowledgement about how pain is processed. |
| OTHER | Exercise | A session of exercise covers the activity, strength and endurance of lower and upper muscles of the extremities. |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2017-09-01
- Completion
- 2017-12-01
- First posted
- 2017-02-06
- Last updated
- 2017-05-03
Source: ClinicalTrials.gov record NCT03044067. Inclusion in this directory is not an endorsement.